Raymond Anderson sold $351K of MNPR stock

Raymond Anderson, Dir of Monopar Therapeutics (MNPR), sold 3,142 shares of MNPR stock worth $351K, per an SEC Form 4 filed Aug 27, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 25, 2026, 2 days before it was made public.

MNPR has moved -35.6% since the trade date, from $110.82 to $71.42 (Nov 6, 2026 close).